期刊文献+

靶向人原癌基因c-fos的shRNA表达质粒的构建及鉴定 被引量:4

Construction and Identification of Short Hairpin RNA Expression Vector Targeting to Human Proto-oncogene c-fos
原文传递
导出
摘要 目的构建靶向人原癌基因c-fos的短发夹RNA(Short hairpin RNA,shRNA)重组真核表达质粒,并进行鉴定。方法构建靶向人c-fos基因的shRNA重组表达质粒Psilencer 3.1-sic-fos,转染乳腺癌MCF-7细胞,采用RT-PCR法检测稳定转染细胞中c-fos基因mRNA的表达。结果重组表达质粒Psilencer 3.1-sic-fos经PCR、双酶切及测序证明构建正确;重组表达质粒在mRNA水平明显抑制了MCF-7细胞c-fos基因的表达(P<0.05)。结论已成功构建了人c-fos基因shRNA重组表达质粒,为深入研究c-fos基因在肿瘤发生、发展过程中的作用提供了技术手段。 Objective To construct and identify a short hairpin RNA(shRNA) expression vector targeting to human proto-oncogene c-fos.Methods Recombinant shRNA expression vector Psilencer3.1-sic-fos targeting to human c-fos gene was constructed and transfected to breast cancer MCF-7 cells.The expression of c-fos mRNA in stably transfected cell was determined by RT-PCR.Results PCR,restriction analysis and sequencing proved that recombinant plasmid Psilencer3.1-sic-fos was constructed correctly.The recombinant plasmid inhibited the expression of c-fos gene at mRNA level in MCF-7 cells significantly.Conclusion The recombinant shRNA expression vector for human c-fos gene was successfully constructed,which provided a technical tool for further study on the role of c-fos gene in genesis and progress of tumors.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第6期682-684,共3页 Chinese Journal of Biologicals
关键词 原癌基因蛋白质C-FOS RNA干扰 乳腺肿瘤 Proto-oncogene protein c-fos RNA interference(RNAi) Breast tumor
  • 相关文献

参考文献11

  • 1Jacque JM, Triques K, Stevenson M. Modulation of HIV-I replication by RNA interference [J]. Nature, 2002, 418 (6896): 435-438.
  • 2Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression replication by RNA interference [J], Hepatology, 2003, 37 (4): 764-770.
  • 3罗欣,刘丹丹,漆洪波,姚珍薇,陈国庆.靶向人Gadd45α基因的shRNA慢病毒载体对缺氧致人脐静脉内皮细胞生物学功能损伤的影响[J].中国生物制品学杂志,2010,23(11):1168-1172. 被引量:12
  • 4郝华,李美宁,赵志兰,杜叶平,秦立元,程牛亮.靶向Pin1基因的shRNA干扰质粒的构建及其对大肠癌SW620细胞Pin1基因的抑制作用[J].中国生物制品学杂志,2009,22(3):213-216. 被引量:2
  • 5刘涛,石艳艳,袁成福,张琴,卜友泉,易发平,刘革力,宋方洲.人Makorin环指蛋白1基因shRNA真核表达质粒的构建及鉴定[J].中国生物制品学杂志,2009,22(5):443-447. 被引量:2
  • 6Liu G, Ding W, Liu X, et al. c-Fos is required for TGFbetal production and the associated paracrine migratory effects of human colon carcinoma cells [J]. Mol Carcinog, 2006, 45 (8): 582-593.
  • 7Durchdewald M, Angel P, Hess J. The transcription factor Fos: a Janus-type regulator in health and disease [J]. Histol Histopathol, 2009, 24 (11): 1451-1461.
  • 8Baan B, Pardali E, ten Dijke P, et al. In situ proximity ligation detection of c-Jun / AP-I dimers reveals increased levels of c-Jun / Fral complexes in aggressive breast cancer cell lines in vitro and in vivo [J]. Mol Cell Proteomics, 2010, 9 (97): 1982-1990.
  • 9Zhu YT, Hu L, Qi C, et al. PRIP promotes tumor tormation through enhancing serum-responsive factor-mediated FOS expression [J]. J Biol Chem, 2009, 284 (21): 14485-14492.
  • 10Rao DD, Senzer N, Cleary MA, et al. Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development [J]. Cancer Gene Ther, 2009, 16 ( 11 ): 807-809.

二级参考文献44

  • 1李红雨,徐茜,朱涛,周金华,邓东锐,王世宣,卢运萍,马丁.宫颈癌细胞株和宫颈上皮组织中Pin1和Cyclin D1的表达及临床意义[J].癌症,2006,25(3):367-372. 被引量:19
  • 2蒋菊香,马珍妮,胡晓慧,董宁征,阮长耿.实时定量PCR分析MT1-MMP/TIMP-2/MMP-2在不同来源人血管内皮细胞株中的表达[J].中国血液流变学杂志,2007,17(1):7-10. 被引量:2
  • 3Zheng H, You H, Zhou X Z, et al. The prolyl isomerase Pinl is a regulator of p53 in genotoxic response. Nature, 2002, 419 (6909): 849-853.
  • 4Ryo A, Liou YC, Lu KP, et al. Prolyl isomerase Pinl: a catalyst for oncogenesis and a potential therapeutic target in cance. J Cell Sci, 2003, 116 (5): 773-783.
  • 5Yaffe MB, Schutkowski M, Shen MZ, et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science, 1997, 278: 1957-1960.
  • 6Kuramochi J, Arai T, Ikeda S, et al. High Pinlexpression is associated with tumor progression in eolorectal cancer. J Surg Oncol, 2006, 94 (2): 155-160.
  • 7Xu YX, Manley JL. The prolyl isomerase Pinl functions in mitotic chromosome condensation. Mol Cell, 2007, 26(20): 287-300.
  • 8Bain JR, Schisler JC, Takeuchi K, et al. An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans. Diabetes, 2004, 53: 2190-2194.
  • 9Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans. Nature, 1998, 391 ( 6669 ): 806 - 811.
  • 10McManus MT, Haines BB, Dillon CP, et al. Small interfering RNA mediated gene silencing in T lymphoeytes 1. J Immunol, 2002, 169 (10): 5754-5760.

共引文献12

同被引文献37

  • 1Ricardo Hlvarez.Present and future evolution of advanced breast canc-er therapy.Breast Cancer Res,2010;12(Suppl 2)∶S1.
  • 2Parekh HS,Liu G,Wei MQ.A new dawn for the use of traditional Chi-nese medicine in cancer therapy.Mol Cancer,2009;8∶21.
  • 3Mahner S,Baasch C,Schwarz J,et al.C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.Br J Cancer,2008;99(8)∶1269-1275.
  • 4Dong XW,Mumper RJ.Nanomedicinal strategies to treat multidrug-re-sistant tumors:current progress.Nanomedicine(Lond),2010;5(4)∶597-615.
  • 5Nam S,Buettner R,Turkson J,et al.Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.Proc Natl Acad Sci U S A,2005,102(17)∶5998-6003.
  • 6Zhou YM,Yau C,Gray JW,et al.Enhanced NFκB and AP-1 transcrip-tional activity associated with antiestrogen resistant breast cancer.BMC Canc-er,2007;7∶59.
  • 7Endicott JA,Ling V.The biochemistry of P-glycoprotein-mediated multi-drug resistance.Annu Rev Biochem,1989;58∶137-171.
  • 8Jema A,Seige R,Xu J,et al. Cancer statistic. Cancer J Clin, 2010, 60(5): 277-300.
  • 9Chen K G, Sikic B I. Molecular pathways: regulation and therapeutic implications of multidrug resistance. Clin Cancer Res, 2012, 18(7): 1863-1869.
  • 10Schiff R, Reddy P, Ahotupa M, et al. Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. Natl Cancer Inst, 2000, 92(23): 1926-1934.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部